Antianxiety and antidepressant effects from a single dose of psychedelic drug persist years later in cancer patients
(New York University) Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy appears to be associated with significant improvements in emotional and existential distress in cancer patients.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
More News: Cancer | Cancer & Oncology | International Medicine & Public Health | Mushrooms | New York University | Psychotherapy | Science | Study